MIR141

MIR141
Identifiers
Aliases	MIR141 , MIRN141, mir-141, microRNA 141
External IDs	OMIM: 612093 GeneCards: MIR141
Gene location (Human) Chr. Chromosome 12 (human) [1] Band 12p13.31 Start 6,964,097 bp [1] End 6,964,191 bp [1]
RNA expression pattern Bgee Human Mouse (ortholog) Top expressed in duodenum gastrocnemius muscle blood islet of Langerhans body of stomach body of pancreas fundus endometrium right lung glomerulus n/a More reference expression data BioGPS n/a
Orthologs Species Human Mouse Entrez 406933 n/a Ensembl ENSG00000207708 n/a UniProt n a n/a RefSeq (mRNA) n/a n/a RefSeq (protein) n/a n/a Location (UCSC) Chr 12: 6.96 – 6.96 Mb n/a PubMed search [2] n/a
Wikidata
View/Edit Human

MicroRNA 141 is a non-coding RNA molecule that in humans is encoded by the MIR141 gene. ^[3]

Function

microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into an RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009].

References

1. GRCh38: Ensembl release 89: ENSG00000207708 - Ensembl, May 2017
2. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
3. "Entrez Gene: MicroRNA 141" . Retrieved 2018-03-23.

Further reading

• Du Y, Xu Y, Ding L, Yao H, Yu H, Zhou T, Si J (2009). "Down-regulation of miR-141 in gastric cancer and its involvement in cell growth". J. Gastroenterol. 44 (6): 556–61. doi:10.1007/s00535-009-0037-7. PMID   19363643. S2CID   22265968.
• Hu M, Xia M, Chen X, Lin Z, Xu Y, Ma Y, Su L (August 2010). "MicroRNA-141 regulates Smad interacting protein 1 (SIP1) and inhibits migration and invasion of colorectal cancer cells". Dig. Dis. Sci. 55 (8): 2365–72. doi:10.1007/s10620-009-1008-9. PMID   19830559. S2CID   25368290.
• Zhang L, Deng T, Li X, Liu H, Zhou H, Ma J, Wu M, Zhou M, Shen S, Li X, Niu Z, Zhang W, Shi L, Xiang B, Lu J, Wang L, Li D, Tang H, Li G (April 2010). "microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network". Carcinogenesis. 31 (4): 559–66. doi: 10.1093/carcin/bgp335 . PMID   20053927.
• Vrba L, Jensen TJ, Garbe JC, Heimark RL, Cress AE, Dickinson S, Stampfer MR, Futscher BW (January 2010). "Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells". PLOS ONE. 5 (1): e8697. Bibcode:2010PLoSO...5.8697V. doi: 10.1371/journal.pone.0008697 . PMC   2805718 . PMID   20084174.
• Uhlmann S, Zhang JD, Schwäger A, Mannsperger H, Riazalhosseini Y, Burmester S, Ward A, Korf U, Wiemann S, Sahin O (July 2010). "miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer". Oncogene. 29 (30): 4297–306. doi: 10.1038/onc.2010.201 . PMID   20514023.
• Banaudha K, Kaliszewski M, Korolnek T, Florea L, Yeung ML, Jeang KT, Kumar A (January 2011). "MicroRNA silencing of tumor suppressor DLC-1 promotes efficient hepatitis C virus replication in primary human hepatocytes". Hepatology. 53 (1): 53–61. doi: 10.1002/hep.24016 . PMID   20967756.
• Ho BC, Yu SL, Chen JJ, Chang SY, Yan BS, Hong QS, Singh S, Kao CL, Chen HY, Su KY, Li KC, Cheng CL, Cheng HW, Lee JY, Lee CN, Yang PC (January 2011). "Enterovirus-induced miR-141 contributes to shutoff of host protein translation by targeting the translation initiation factor eIF4E". Cell Host Microbe. 9 (1): 58–69. doi: 10.1016/j.chom.2010.12.001 . PMID   21238947.
• Imanaka Y, Tsuchiya S, Sato F, Shimada Y, Shimizu K, Tsujimoto G (April 2011). "MicroRNA-141 confers resistance to cisplatin-induced apoptosis by targeting YAP1 in human esophageal squamous cell carcinoma". J. Hum. Genet. 56 (4): 270–6. doi: 10.1038/jhg.2011.1 . PMID   21289630.
• Cheng H, Zhang L, Cogdell DE, Zheng H, Schetter AJ, Nykter M, Harris CC, Chen K, Hamilton SR, Zhang W (March 2011). "Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis". PLOS ONE. 6 (3): e17745. Bibcode:2011PLoSO...617745C. doi: 10.1371/journal.pone.0017745 . PMC   3060165 . PMID   21445232.

This article incorporates text from the United States National Library of Medicine, which is in the public domain.